Skip to content

Impact of genetic polymorphism in patients with chronic hepatitis B

Impact of genetic polymorphism in patients with chronic hepatitis B - Impact of genetic polymorphism in patients with chronic hepatitis B

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000024420
Enrollment
500
Registered
2016-10-15
Start date
2016-10-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis B

Interventions

None listed

Sponsors

The department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with positive HBs antigen or patients with positive HBs antibody and/or HBc antibody

Exclusion criteria

Exclusion criteria: patients disqualified by principal investigator

Design outcomes

Primary

MeasureTime frame
1)elucidate the relation between IL28B polymorphism and chronic hepatitis B 2)elucidate the relation between HLA polymorphism and chronic hepatitis B

Countries

Japan

Contacts

Public ContactRyoko Yamada

Osaka University Graduate School of Medicine The department of Gastroenterology and Hepatology

ryo726@gh.md.osaka-u.ac.jp0668793621

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026